Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P van Brummelen

Showing results (21-30 of 153) with videos related to

Pageof 16
Sort By:
Clinical Pharmacokinetics|January 1, 1987
Nifedipine. Relationship between pharmacokinetics and pharmacodynamicsC H Kleinbloesem, P van Brummelen, D D Breimer
European Journal of Clinical Investigation|June 1, 1985
Is the renal kallikrein system relevant to sodium sensitivity in patients with essential hypertensionM I Koolen, M R Daha, P van Brummelen
American Journal of Hypertension|April 1, 1991
Arterial and venous effects of atrial natriuretic peptide in the human forearmC J Doorenbos, G J Blauw, P van Brummelen
Annals of Internal Medicine|December 1, 1985
Desmopressin and hypotensionE J Brommer, P van Brummelen, F H Derkx
British Journal of Clinical Pharmacology|January 1, 1986
Alpha-adrenergic receptors in human blood vesselsP van Brummelen, K Jie, P A van Zwieten
Clinical Nephrology|March 1, 1989
Correlates of plasma atrial natriuretic peptide levels in renal transplant recipientsC J Doorenbos, M R Daha, P van Brummelen
Lancet (London, England)|January 19, 1980
Captopril-associated agranulocytosisP van Brummelen, R Willemze, W D Tan, et al.
Clinical Physiology and Biochemistry|January 1, 1990
Pathophysiological and pharmacotherapeutic aspects of serotonin and serotonergic drugsP A van Zwieten, G J Blauw, P van Brummelen
Pharmacology & Toxicology|June 1, 1992
Serotonergic receptors and drugs in hypertensionP A van Zwieten, G J Blauw, P van Brummelen
The American Journal of Medicine|October 5, 1984
Role of alpha adrenoceptors in hypertension and in antihypertensive drug treatmentP A Van Zwieten, P B Timmermans, P Van Brummelen
Pageof 16

Showing results (21-30 of 153) with videos related to

Sort By:
Pageof 16
Clinical Pharmacokinetics|January 1, 1987
Nifedipine. Relationship between pharmacokinetics and pharmacodynamicsC H Kleinbloesem, P van Brummelen, D D Breimer
European Journal of Clinical Investigation|June 1, 1985
Is the renal kallikrein system relevant to sodium sensitivity in patients with essential hypertensionM I Koolen, M R Daha, P van Brummelen
American Journal of Hypertension|April 1, 1991
Arterial and venous effects of atrial natriuretic peptide in the human forearmC J Doorenbos, G J Blauw, P van Brummelen
Annals of Internal Medicine|December 1, 1985
Desmopressin and hypotensionE J Brommer, P van Brummelen, F H Derkx
British Journal of Clinical Pharmacology|January 1, 1986
Alpha-adrenergic receptors in human blood vesselsP van Brummelen, K Jie, P A van Zwieten
Clinical Nephrology|March 1, 1989
Correlates of plasma atrial natriuretic peptide levels in renal transplant recipientsC J Doorenbos, M R Daha, P van Brummelen
Lancet (London, England)|January 19, 1980
Captopril-associated agranulocytosisP van Brummelen, R Willemze, W D Tan, et al.
Clinical Physiology and Biochemistry|January 1, 1990
Pathophysiological and pharmacotherapeutic aspects of serotonin and serotonergic drugsP A van Zwieten, G J Blauw, P van Brummelen
Pharmacology & Toxicology|June 1, 1992
Serotonergic receptors and drugs in hypertensionP A van Zwieten, G J Blauw, P van Brummelen
The American Journal of Medicine|October 5, 1984
Role of alpha adrenoceptors in hypertension and in antihypertensive drug treatmentP A Van Zwieten, P B Timmermans, P Van Brummelen
Pageof 16